cefepime Powder for solution for injection 1 g
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #21499
This CTD dossier owner and manufacturer is a major player in the global market, with established production bases across multiple regions. They boast a wide range of products, including prescription medications and over-the-counter drugs, catering to diverse therapeutic areas such as respiratory health, pain management, gastrointestinal disorders, and infectious diseases. Their product portfolio encompasses various dosage forms like oral solids, injections, topical creams, and infusions, manufactured under strict GMP certifications. The company holds several patents for their innovative drug formulations, solidifying its competitive advantage in the industry.
Manufacturer usually replies in 6 days
Cefepime is an antibiotic used to treat a wide range of bacterial infections, including intraabdominal, kidney, skin, urinary tract infections as well as pneumonia. Suppliers of cefepime market it in the form of powders for injectable solutions.
The developer and earliest manufacturer of cefepime is Bristol-Myers Squibb who first introduced it into the market in 1994 under the trade name Maxipime. Currently, major manufacturers of cefepime medications include companies such as Berr Chem, Hangzhou Viwa, Nectar Lifesciences, ACS Dobfar, and Qilu Pharmaceutical.
Cefepime suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cefepime manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 10g of cefepime powder falls into an approximate range of 120 EUR to 160 EUR.